Pacific Biosciences of California (PACB) 10-Q2013 Q1 Quarterly report

Filed: 10 May 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Good

New words: acceleration, affiliated, affirmative, annum, answered, approach, backed, bear, bifurcated, budget, calendar, conference, dedicate, Deerfield, default, description, detailed, disadvantage, embedded, exceeded, Facilityand, Facilityfor, fee, flexibility, inclusive, July, line, loan, memorandum, Milestone, newly, partly, pledged, prejudice, proceed, proceeding, promissory, rearrangement, reclassification, repay, repayment, reverse, scheme, sequestration, show, simple, sixty, spin, split, stipulated, stipulation, tentative, theBurlingameaction, thereon, unpaid, voluntarily, Warrant, withholding

Removed: add, amendment, assessment, assured, began, borrowing, capitalization, carried, categorization, cell, collectability, combination, committee, consecutive, consideration, contractually, corroborated, counterparty, defer, deferred, deliverable, delivered, depending, designated, determining, evidence, exceed, FASB, finalization, fluctuate, frequency, gradually, group, headcount, identical, identification, Illumina, impairment, inactive, incremental, initiate, input, insignificant, insufficient, intent, interim, investee, issuer, issuing, judged, length, lowest, measure, measurement, measuring, minimize, mix, OCI, periodically, persuasive, phase, Premium, priced, producing, project, provision, ratably, receipt, recognize, recognizing, refund, reimbursement, resell, restructuring, separate, separately, significance, spot, standalone, stated, structure, supported, temporary, undelivered, unit, unrealized, vendor, view, VSOE

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PACB similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification of CEO Furnished Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant To

Section 906 of The Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Pacific Biosciences of California, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2013, as filed with the Securities and Exchange Commission on the date hereof, I, Michael Hunkapiller, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that,

(i) the Quarterly Report of the Company on Form 10-Q for the period ended March 31, 2013 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 10, 2013				/s/ Michael Hunkapiller
				Michael Hunkapiller
				Chairman, President and Chief Executive Officer (Principal Executive Officer)